AAVCAGsCD59 for the Treatment of Wet AMD
NCT03585556
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Wet Age-related Macular Degeneration
Interventions
DRUG:
Intravitreal anti-VEGF
BIOLOGICAL:
Intravitreal AAVCAGsCD59
DRUG:
Oral prednisolone
Sponsor
Janssen Research & Development, LLC